Literature DB >> 3964979

Astrocytomas in childhood: a population-based study.

G J Dohrmann, J R Farwell, J T Flannery.   

Abstract

A population-based study of astrocytomas occurring in children is reported. A population-based study eliminates referral bias and the bias of a series based on the experience of a given medical center or a particular surgeon. In a 42-year period, 179 such cases were diagnosed. The average age at diagnosis was 8.9 years. Over one-half of the astrocytic tumors were located in the cerebellum. A peak in the number of astrocytomas was noted between 1965 and 1970. Cumulative probability of survival of children with intracranial astrocytomas at 6 months and at 1, 2, and 5 years was 0.824, 0.752, 0.732, and 0.667; by 10 years and 20 years the cumulative probability of survival had fallen to 0.607 and 0.538. The shortest survival was observed with brainstem tumors, with an average survival of 19 months. Longer survivals were noted with tumors of the cerebral hemispheres: 0.779, 0.748, 0.678 and 0.628 at 1, 2, 5, and 10 years, respectively. The longest survivals were in those children with cerebellar astrocytomas: at 1 year they had an 0.837 probability of survival and at 20 years, 0.675.

Entities:  

Mesh:

Year:  1985        PMID: 3964979     DOI: 10.1016/0090-3019(85)90162-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  10 in total

1.  Long-term survival in children under 3 years of age with low-grade astrocytoma.

Authors:  Roberto Rivera-Luna; Marta Zapata-Tarrés; Aurora Medina-Sansón; Enrique López-Aguilar; Ana Niembro-Zúñiga; J Amador Zarco; Alfonso Marhx-Bracho; Fernando Rueda-Franco; Leticia Bornstein-Quevedo
Journal:  Childs Nerv Syst       Date:  2007-01-17       Impact factor: 1.475

2.  Survival and long-term health and cognitive outcomes after low-grade glioma.

Authors:  Gregory T Armstrong; Heather M Conklin; Sujuan Huang; Deokumar Srivastava; Robert Sanford; David W Ellison; Thomas E Merchant; Melissa M Hudson; Mary Ellen Hoehn; Leslie L Robison; Amar Gajjar; E Brannon Morris
Journal:  Neuro Oncol       Date:  2010-12-22       Impact factor: 12.300

3.  Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic target.

Authors:  Stuart J Smith; Angela Long; Jennifer H Barrow; Donald C Macarthur; Beth Coyle; Richard G Grundy
Journal:  Neuro Oncol       Date:  2011-08-17       Impact factor: 12.300

Review 4.  Epidemiology of Glioblastoma Multiforme-Literature Review.

Authors:  Szymon Grochans; Anna Maria Cybulska; Donata Simińska; Jan Korbecki; Klaudyna Kojder; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

5.  Proliferative activity as measured by MIB-1 labeling index and long-term outcome of cerebellar juvenile pilocytic astrocytomas.

Authors:  Karl Roessler; Alexander Bertalanffy; Hussun Jezan; Achmed Ba-Ssalamah; Irene Slavc; Thomas Czech; Herbert Budka
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

Review 6.  The impact of technical adjuncts in the surgical management of cerebral hemispheric low-grade gliomas of childhood.

Authors:  M S Berger
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

7.  The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas.

Authors:  Kavita K Mishra; Dev R Puri; Brian T Missett; Kathleen R Lamborn; Michael D Prados; Mitchel S Berger; Anuradha Banerjee; Nalin Gupta; William M Wara; Daphne A Haas-Kogan
Journal:  Neuro Oncol       Date:  2006-02-22       Impact factor: 12.300

8.  Combined modality therapy for poorly differentiated gliomas of the posterior fossa in children: a Children's Cancer Group report.

Authors:  Salvatore J Bertolone; Allan J Yates; James M Boyett; Dana Wallace; Jonathan L Finlay
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

9.  CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma.

Authors:  Stuart J Smith; Hanna Tilly; Jennifer H Ward; Donald C Macarthur; James Lowe; Beth Coyle; Richard G Grundy
Journal:  Acta Neuropathol       Date:  2012-02-07       Impact factor: 17.088

10.  Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma.

Authors:  Nataliya Zhukova; Revathi Rajagopal; Adrienne Lam; Lee Coleman; Peter Shipman; Thomas Walwyn; Molly Williams; Michael Sullivan; Martin Campbell; Kanika Bhatia; Nicholas G Gottardo; Jordan R Hansford
Journal:  Cancer Med       Date:  2018-12-19       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.